Technology Journal Nepal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal Nepal.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 5, 2026

January 5, 2026

ElevateBio Appoints Christopher Murphy as Chief Executive Officer and Member of the Board of Directors

GlobeNewswire

January 5, 2026

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

GlobeNewswire

January 5, 2026

BridgeBio to Participate in the J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis

GlobeNewswire

January 5, 2026

3D Systems Accelerates Growth in Aerospace & Defense with Strategic Investments and Projected Leadership Position

GlobeNewswire

January 5, 2026

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

GlobeNewswire

January 5, 2026

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

January 5, 2026

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH

GlobeNewswire

January 5, 2026

Allot to Present at the Needham Growth Conference on January 14, 2026

GlobeNewswire

January 5, 2026

Zenas BioPharma Announces Positive Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

GlobeNewswire

January 5, 2026

Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Syndax Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Maze Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

GlobeNewswire

January 5, 2026

Upstream Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 5, 2026

Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines

GlobeNewswire